KERICURE INC.
Wesley Chapel, FL · Founded 2011 · CIK 0001555663 · Medtech · Private
Natural, hypoallergenic wound care and first aid topical formulas
kericuremedical.com →- Grants
- $2.0M
- 3 awards
- Sector median: 1
- Raised
- $310K
- 2 Form D · Apr 2014
- 149 months since last filing
- Contracts
- $5.3M
- 2 awards · Defense
- #120 of 4531 in medtech
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $310,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Federal contract | Department of Defense · Dha 2020.1 SBIR Direct To Phase II Medical R&d Contract For Proposal #H2D-0023, Titled: "deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care" | $2,199,745 | |
| Federal grant | Department of Defense · Phase I · Ruggedized Spray on Antimicrobial Wound Dressing for Treatment of Multiple Sulfur Mustard-Induced Dermal Injuries in Theater to Mitigate Infection, Pain and Promote Healing | $167,470 | |
| Federal grant | Department of Defense · Phase II · Deployable Wound Care Products to Decrease Preventable Death Outcomes by Mitigating Infection on Battlefield and through Long Term Care | $549,861 | |
| Federal grant | Department of Defense · Phase II · Deployable Wound Care Products to Decrease Preventable Death Outcomes by Mitigating Infection on Battlefield and through Long Term Care | $1,299,857 | |
| Federal contract | Department of Defense · Kericure, Inc. Dha SBIR Phase III Clinical Validation Of A Portable, Ruggedized Antimicrobial Wound Dressing In Management Of Large Surface Area Burns For Prolonged Field Care And Long-term Care | $3,111,212 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 117 | LAMBDAVISION INCORPORATED | $5.4M | — |
| 118 | MOTION CONTROL, INC | $5.4M | — |
| 119 | VIA THERAPEUTICS, LLC | $5.4M | — |
| 120 | KERICURE INC. | $5.3M | $310K |
| 121 | PERFUSION MEDICAL LLC | $5.2M | — |
| 122 | Gate Scientific, Inc. | $5.1M | — |
| 123 | AA PLASMA LLC | $5.0M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Tami BrothertonExecutive Officer
- Vivian LauderdaleDirector
- Daniel McLainDirector
- Kerriann OppDirector · Executive Officer
- Jesus RodriguezDirector
- Edward TurosDirector
Patents
- Therapeutic Medical Device and Methods of Useapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.